about
Redefining the viral reservoirs that prevent HIV-1 eradicationRecent developments in human immunodeficiency virus-1 latency researchT memory stem cells and HIV: a long-term relationshipProteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.Combinatorial anti-HIV gene therapy: using a multipronged approach to reach beyond HAARTA polymorphism in the leptin gene promoter is associated with anemia in patients with HIV diseaseHIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapyCombined Antiviral Therapy Using Designed Molecular Scaffolds Targeting Two Distinct Viral Functions, HIV-1 Genome Integration and Capsid AssemblyLatent HIV-1 infection occurs in multiple subsets of hematopoietic progenitor cells and is reversed by NF-κB activation.Short communication: Colony-forming hematopoietic progenitor cells are not preferentially infected by HIV type 1 subtypes A and D in vivo.Early Antiretroviral Therapy Is Associated with Lower HIV DNA Molecular Diversity and Lower Inflammation in Cerebrospinal Fluid but Does Not Prevent the Establishment of Compartmentalized HIV DNA PopulationsNeutropenia during HIV infection: adverse consequences and remedies.Substance abuse, HIV-1 and hepatitisHepatitis B Virus Replication in CD34+ Hematopoietic Stem Cells From Umbilical Cord Blood.Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic developmentRole of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis.Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cellsAchieving a cure for HIV infection: do we have reasons to be optimistic?Cellular and molecular mechanisms involved in the establishment of HIV-1 latency.Making a Short Story Long: Regulation of P-TEFb and HIV-1 Transcriptional Elongation in CD4+ T Lymphocytes and Macrophages.Broadly neutralizing antibodies: An approach to control HIV-1 infection.HIV infection: focus on the innate immune cells.CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route.Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism.Humanized mouse model of mast cell-mediated passive cutaneous anaphylaxis and passive systemic anaphylaxis.Current Peptide and Protein Candidates Challenging HIV Therapy beyond the Vaccine Era.Hematopoietic cell transplantation and HIV cure: where we are and what next?Hematopoietic stem cells and HIV infection.Mast cells in periodontal disease of individuals with and without HIV undergoing highly active antiretroviral therapy.
P2860
Q26827255-7985726F-9EDD-4B44-81C2-5E13CCEC047EQ27013114-A236BFDD-E069-4101-8221-11077B09473DQ27023930-01E72CE2-4ED7-4F67-A046-6182F650E295Q33589167-BA40450D-7A30-47CD-8F41-9DA031B33916Q34647798-E1FB0E67-321B-486A-806C-F4D03F2E0B7FQ35553295-3EA29104-F748-4028-8E6E-327F7B462460Q35766026-66AB7EE9-2674-455F-9640-2C87BB97CDB7Q36030091-CBEFED9A-850C-49B4-A9E4-041663AEECE0Q36155046-1A4E854A-4C5F-4966-B9BC-0A7F8E208F3EQ36177510-F9A5BC02-A7F6-43A8-A460-DD548C71AB15Q36238501-FBD42583-6D0F-40D6-A46F-60116B0C5796Q36919713-5CC3DFDE-23D1-4EDB-83DF-06DBE0CA7480Q37003023-4602C1EB-AE88-4A66-A157-650082EF6AABQ37032202-2875A53E-DE4F-41AB-9C5E-B561C2D79870Q37127522-CC1885E0-EF67-473B-BDFF-824411DA6F29Q37133136-922A43C9-DDAE-400F-A96E-636D09C94159Q37403787-FB2D9FB4-DAAA-4DA4-BD1E-80A56BF6650AQ37980423-293EBD70-1E9D-41F3-8361-0682247F4EA5Q38078562-FA7B6663-2C85-4D78-B8AC-2420555A6893Q38212042-FEE8B40E-65F8-43F9-9614-199D1492AE83Q38811735-B4C97658-39A4-4A41-9B7E-BD3C20281692Q38945041-B8E827F8-DD0A-4F76-BE3C-14C3847084B4Q39197846-EF1964D4-A80E-4179-9BA0-048DF5DEC7B6Q39314021-293C40A3-C714-4AEF-B17F-4602AEA338AAQ41036510-6ABB74C0-8C38-4B54-A613-8038DE8311D3Q41928050-2038B19F-311F-4A28-8C47-FD10BC6A5FA8Q42925261-155E34D3-D62E-4AED-B5C2-BA823337193CQ43161927-76F598D8-F5DA-4612-8D37-ECB7EECF1B73Q44237421-E18D2D57-2A9A-4EFF-BBB1-4FF9D3FB8326
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Hematopoietic stem/precursor cells as HIV reservoirs.
@ast
Hematopoietic stem/precursor cells as HIV reservoirs.
@en
Hematopoietic stem/precursor cells as HIV reservoirs.
@nl
type
label
Hematopoietic stem/precursor cells as HIV reservoirs.
@ast
Hematopoietic stem/precursor cells as HIV reservoirs.
@en
Hematopoietic stem/precursor cells as HIV reservoirs.
@nl
prefLabel
Hematopoietic stem/precursor cells as HIV reservoirs.
@ast
Hematopoietic stem/precursor cells as HIV reservoirs.
@en
Hematopoietic stem/precursor cells as HIV reservoirs.
@nl
P2860
P1476
Hematopoietic stem/precursor cells as HIV reservoirs
@en
P2093
Kathleen L Collins
P2860
P356
10.1097/COH.0B013E32834086B3
P577
2011-01-01T00:00:00Z